RxDoctor Payments Data

Felicia Chidolue

Family · Houston, TXNPI 1952549578

Payments from drug & device makers

What this record shows

21 manufacturers reported payments, led by CSL Behring at 28.0% of the total. Reporting peaked in 2024 at $5,879 and has fallen 80.8% since, to $1,126 in 2025. Among family clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$8,463in general payments, 2019–2025

Across 167 payments — averaging $50.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • CSL Behring$2K
  • AstraZeneca$2K
  • Bayer$2K
  • Otsuka America Pharmaceutical, Inc.$396
  • Amgen$387
  • Calliditas Therapeutics US Inc.$328
  • plus $1K from 15 others

What the payments were for

  • Travel & lodging$4,23650%
  • Food & beverage$4,22750%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,463 in reported general payments places this provider in the 95th percentile of 15,456 family providers in Texas.

See all family providers in Texas →

Other family in Houston

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →